Off-target activity

Drug biological activity

Off-target activity is biological activity of a drug that is different from and not at that of its intended biological target. It most commonly contributes to side effects. However, in some cases, off-target activity can be taken advantage of for therapeutic purposes. An example of this is the repurposing of the antimineralocorticoid and diuretic spironolactone, which was found to produce feminization and gynecomastia as side effects, for use as an antiandrogen in the treatment of androgen-dependent conditions like acne and hirsutism in women.[1]

See also

  • Antitarget

References

  1. ^ Mohammadi E, Benfeitas R, Turkez H, Boren J, Nielsen J, Uhlen M, Mardinoglu A (September 2020). "Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning". Cancers (Basel). 12 (9): 2694. doi:10.3390/cancers12092694. PMC 7563533. PMID 32967266.


  • v
  • t
  • e
Pharmacology
Ligand (biochemistry)
Excitatory
Inhibitory
Pharmacodynamics
Activity at receptor
  • Mechanism of action
  • Mode of action
  • Binding
  • Receptor (biochemistry)
  • Desensitization (medicine)
  • Other effects of ligand
    Analysis
    Metrics
    Pharmacokinetics
    Metrics
    LADME
    Related
    fields
    Neuroscience and psychology
    Medicine
    Biochemistry and genetics
    Toxicology
    Drug discovery
    Other
  • Coinduction (anesthetics)
  • Combination therapy
  • Functional analog (chemistry)
  • Polypharmacology
  • Chemotherapy
  • Lists of drugs
  • WHO list of essential medicines
  • Tolerance and resistance
    Antimicrobial pharmacology